Viewing nowCresban Tablet 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Seongwon Adcock Pharmaceutical Co., Ltd.

MFDS item code 201403493 · Approved 2014.07.29 · Insurance code 664901040
Improvement of dyslipidemia; inhibition of the progression of atherosclerosis; prevention of cardiovascular disease
This medicine is primarily used for patients with primary hypercholesterolemia and mixed dyslipidemia that are difficult to manage with diet and exercise. It can also be used in combination with other treatments for patients with homozygous familial hypercholesterolemia, reducing total cholesterol and LDL-cholesterol levels in hypercholesterolemic patients and delaying the progression of atherosclerosis. It is also used as an adjunct to diet in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia. Additionally, it is beneficial for patients with primary dysbetalipoproteinemia. Finally, this medication is used in adult patients with elevated high-sensitivity C-reactive protein and additional cardiovascular risk factors to reduce the risk of stroke, myocardial infarction, and revascularization procedures.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and should continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased up to a maximum of 20 milligrams daily. 3. Elderly patients: Dose adjustment is not required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, whereas an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administration of doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For instance, individuals allergic to its components, those with severely impaired liver function, those with muscle disorders, and women who are pregnant or breastfeeding should avoid taking this medication. Additionally, it should be avoided in patients with severely reduced kidney function or those taking specific medications. This medicine can affect muscles, so caution is warranted in patients experiencing muscle pain or myopathy symptoms. It is important to regularly monitor liver function and muscle status while using this medication. Individuals with a history of liver disease or heavy alcohol consumption should be especially cautious, and those with hypothyroidism should have this treated prior to starting therapy. If symptoms such as muscle pain, weakness, or fatigue occur, patients should immediately inform their physician and undergo examination, and in severe cases, drug therapy may need to be discontinued. This medication may raise blood sugar levels in some patients, so individuals at risk of diabetes should regularly check their blood glucose levels. Furthermore, this drug can interact with other medications, so it is crucial to inform healthcare providers of any other drugs being taken. Special caution is advised when taken with certain antiviral drugs, immunosuppressants, and fibrates. Women of childbearing potential must use appropriate contraception and should not take this medication during pregnancy. Breastfeeding women are also advised against using this drug. In the case of overdose, there is no specific antidote, so treatment should be based on symptoms, and monitoring of liver function and muscle enzyme levels is necessary. This medication is not known to significantly affect driving or machinery operation, but caution is advised as dizziness may occur. Lastly, this medication may show higher concentrations in some Asian individuals, indicating a potential need for dosage adjustments. To use safely, it is important to follow healthcare provider instructions and undergo regular testing.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the medication's efficacy and ensure safe use.
Pink round film-coated tablet
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Seongwon Adcock Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.